• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析患者捏力与心血管事件及全因死亡率的相关性。

Associations between pinch strength, cardiovascular events and all-cause mortality in patients undergoing maintenance hemodialysis.

机构信息

Clinical Collage of Medicine, Guizhou Medical University, Guiyang, China.

Department of Nephrology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

BMC Nephrol. 2024 May 2;25(1):150. doi: 10.1186/s12882-024-03587-x.

DOI:10.1186/s12882-024-03587-x
PMID:38698329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11064367/
Abstract

BACKGROUND AND AIMS

Patients undergoing maintenance hemodialysis (MHD) experience increased mortality and cardiovascular disease (CVD) risks; however, the potential connection between pinch strength (PS) and the prognosis of these patients remains unknown. Consequently, this study aimed to comprehensively assess the influence of PS and handgrip strength (HGS) on both survival and cardiovascular events (CVE) in patients undergoing MHD.

METHODS

Data were gathered from patients undergoing MHD at the Hemodialysis Center of Guangzhou Red Cross Hospital in March 2021. We performed a retrospective follow-up spanning 24 months, with death serving as the primary endpoint for observation and CVE as the secondary endpoint. Multifactorial Cox regression analysis, Kaplan-Meier survival curves, trend tests, and restricted cubic spline were applied to explore the association.

RESULTS

During a 24-month follow-up, data were collected from 140 patients undergoing MHD with an average age of 66.71 ± 12.61 years. Among them, 52 (37.14%) experienced mortality, whereas 36 (40.00%) had CVE without baseline CVD. Kaplan-Meier survival curves demonstrated better survival rates and reduced CVE risk for patients in the second, third, and fourth quartiles compared with those in the first quartile for PS. Adjusted analyses in different models revealed higher PS levels were independently associated with all-cause mortality (major model, model 4, HR, 0.78; 95% CI, 0.64-0.95) but not with CVE risk (unadjusted HR, 0.90; 95% CI, 0.77-1.05). Compared with lower quartile PS levels, higher PS levels significantly reduced all-cause mortality (HR, 0.31; 95% CI, 0.10-1.02), and this trend remained consistent (P for trend = 0.021). Finally, the restricted cubic spline method using different models showed a linear relationship between PS and all-cause mortality (P > 0.05), when PS exceeded 4.99 kg, the all-cause mortality of MHD patients significantly decreased.

CONCLUSIONS

PS was independently associated with all-cause mortality but not with CVE in patients undergoing MHD.

摘要

背景和目的

接受维持性血液透析(MHD)的患者死亡率和心血管疾病(CVD)风险增加;然而,握力(PS)与这些患者预后之间的潜在联系尚不清楚。因此,本研究旨在全面评估 PS 和手握力(HGS)对 MHD 患者生存和心血管事件(CVE)的影响。

方法

本研究的数据来自 2021 年 3 月在广州红十字会医院血液透析中心接受 MHD 的患者。我们进行了为期 24 个月的回顾性随访,以死亡为主要观察终点,以 CVE 为次要终点。采用多因素 Cox 回归分析、Kaplan-Meier 生存曲线、趋势检验和限制性立方样条分析来探讨相关性。

结果

在 24 个月的随访期间,共收集了 140 名接受 MHD 的患者的数据,平均年龄为 66.71±12.61 岁。其中,52 名(37.14%)患者死亡,36 名(40.00%)患者无基线 CVD 发生 CVE。Kaplan-Meier 生存曲线显示,与 PS 第一四分位相比,PS 处于第二、三、四分位的患者生存率更高,CVE 风险更低。在不同模型的调整分析中,较高的 PS 水平与全因死亡率独立相关(主要模型,模型 4,HR,0.78;95%CI,0.64-0.95),但与 CVE 风险无关(未调整 HR,0.90;95%CI,0.77-1.05)。与较低 PS 四分位相比,较高 PS 水平显著降低了全因死亡率(HR,0.31;95%CI,0.10-1.02),且这种趋势一致(趋势 P 值=0.021)。最后,使用不同模型的限制性立方样条方法显示 PS 与全因死亡率之间存在线性关系(P>0.05),当 PS 超过 4.99 kg 时,MHD 患者的全因死亡率显著降低。

结论

PS 与 MHD 患者的全因死亡率独立相关,但与 CVE 无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/2725ef4d403f/12882_2024_3587_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/8cbd0ac6713f/12882_2024_3587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/8a88f09c5c3b/12882_2024_3587_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/2725ef4d403f/12882_2024_3587_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/8cbd0ac6713f/12882_2024_3587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/8a88f09c5c3b/12882_2024_3587_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95c4/11064367/2725ef4d403f/12882_2024_3587_Fig3_HTML.jpg

相似文献

1
Associations between pinch strength, cardiovascular events and all-cause mortality in patients undergoing maintenance hemodialysis.维持性血液透析患者捏力与心血管事件及全因死亡率的相关性。
BMC Nephrol. 2024 May 2;25(1):150. doi: 10.1186/s12882-024-03587-x.
2
The relationship between survival rate and intradialytic blood pressure changes in maintenance hemodialysis patients.维持性血液透析患者生存率与透析期间血压变化的关系
Ren Fail. 2017 Nov;39(1):417-422. doi: 10.1080/0886022X.2017.1305407.
3
Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.肺动脉高压作为血液透析患者心血管死亡率和事件的独立预测因子。
Int Urol Nephrol. 2014 Jan;46(1):141-9. doi: 10.1007/s11255-013-0486-z. Epub 2013 Jun 21.
4
Impact of serum albumin level and variability on short-term cardiovascular-related and all-cause mortality in patients on maintenance hemodialysis.维持性血液透析患者血清白蛋白水平及变化对短期心血管相关及全因死亡率的影响。
Medicine (Baltimore). 2021 Oct 29;100(43):e27666. doi: 10.1097/MD.0000000000027666.
5
Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.左心室质量指数和主动脉弓钙化评分是维持性血液透析患者独立的死亡预测指标。
Hemodial Int. 2012 Oct;16(4):504-11. doi: 10.1111/j.1542-4758.2012.00700.x. Epub 2012 Apr 22.
6
Association between serum β-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in chinese patients undergoing maintenance hemodialysis.血清β-微球蛋白水平与维持性血液透析中国患者全因和心血管疾病死亡风险的关系。
BMC Nephrol. 2023 Jun 13;24(1):170. doi: 10.1186/s12882-023-03191-5.
7
Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis.肌少症和超声心动图参数对维持性血液透析患者心血管事件和死亡的预测价值。
PeerJ. 2022 Nov 23;10:e14429. doi: 10.7717/peerj.14429. eCollection 2022.
8
The impact of chronic pre-dialysis hyponatremia on clinical outcomes in maintenance hemodialysis patients.慢性透析前低钠血症对维持性血液透析患者临床结局的影响。
Int Urol Nephrol. 2022 Dec;54(12):3221-3232. doi: 10.1007/s11255-022-03241-1. Epub 2022 Jul 2.
9
Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.维持性血液透析患者的基线血清镁水平及其变异性与死亡率的关系。
Kidney Blood Press Res. 2019;44(2):222-232. doi: 10.1159/000498957. Epub 2019 Mar 28.
10
Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.骨保护素与患有心血管疾病的血液透析患者的死亡率
Clin Nephrol. 2013 Sep;80(3):161-7. doi: 10.5414/CN107803.

本文引用的文献

1
Increasing muscular strength to improve cardiometabolic risk factors.增加肌肉力量以改善心血管代谢危险因素。
Clin Investig Arterioscler. 2023 May-Jun;35(3):144-154. doi: 10.1016/j.arteri.2022.12.002. Epub 2022 Dec 15.
2
Association between Handgrip Strength and the Systemic Immune-Inflammation Index: A Nationwide Study, NHANES 2011-2014.握力与全身免疫炎症指数的相关性:一项全国性研究,NHANES2011-2014。
Int J Environ Res Public Health. 2022 Oct 20;19(20):13616. doi: 10.3390/ijerph192013616.
3
Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis.
透析患者肌少症的患病率及其对心血管事件和死亡率的影响:系统评价和荟萃分析。
Nutrients. 2022 Sep 30;14(19):4077. doi: 10.3390/nu14194077.
4
Associations between dynapenia, cardiovascular hospitalizations, and all-cause mortality among patients on haemodialysis.血液透析患者 dynapenia 与心血管住院治疗和全因死亡率之间的关联。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2417-2425. doi: 10.1002/jcsm.13039. Epub 2022 Aug 2.
5
Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity.手握力与心血管代谢性多种疾病发病率和全因死亡率的关系。
BMC Med. 2022 Jun 3;20(1):191. doi: 10.1186/s12916-022-02389-y.
6
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2021年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2022 Apr;79(4 Suppl 1):A8-A12. doi: 10.1053/j.ajkd.2022.02.001.
7
Epidemiology of haemodialysis outcomes.血液透析结局的流行病学。
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
8
Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study.中老年人群中肌肉减少症与心血管疾病的关联:来自中国健康与养老追踪调查的结果
EClinicalMedicine. 2022 Jan 10;44:101264. doi: 10.1016/j.eclinm.2021.101264. eCollection 2022 Feb.
9
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.透析患者肌少症的诊断、患病率和死亡率:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):145-158. doi: 10.1002/jcsm.12890. Epub 2022 Jan 5.
10
A Systematic Review of Handgrip Strength Measurement in Clinical and Epidemiological Studies of Kidney Disease: Toward a Standardized Approach.一项关于肾脏病临床和流行病学研究中握力测量的系统评价:迈向标准化方法。
J Ren Nutr. 2022 Jul;32(4):371-381. doi: 10.1053/j.jrn.2021.06.005. Epub 2021 Jul 20.